Tumori Journal

Papers
(The TQCC of Tumori Journal is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Corrigendum to: AIRO Breast Cancer Group Best Clinical Practice 2022 Update43
Associations between vascular endothelial growth factor polymorphisms and response to 5-FU-based pharmaceutical therapy in esophageal squamous cell carcinoma: A meta-analysis35
Towards a better registration of neuroendocrine neoplasms: The results of the Italian retrospective population-based study24
Complete response to immunotherapy in sinonasal undifferentiated carcinoma18
Corrigendum to “Lung metastasectomy for osteosarcoma in children, adolescents, and young adults: proof of permanent cure”17
Reply to comments on: Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy16
Challenges of cancer immunotherapy and chemotherapy during the COVID-19 pandemic15
Get up, stand up: Alongside adolescents and young adults with cancer for their right to be forgotten14
Laparoscopic adrenalectomy for suspected adrenal mass in lung cancer: ganglioneuroma14
Immunohistochemical Expression of CD68 in Triple Negative Invasive Ductal Carcinoma of the Breast and its Correlation with Clinicopathological Parameters13
Self-perceived attitudes of Italian oncology nurses towards clinical trial involvement: A cohort observational study12
Challenges in the management of advanced NSCLC among Italian oncologists: a 2019 national survey unfolds regional disparities12
Have we made progress in taking care of adolescents and young adults with cancer? Results of a European multi-professional survey11
Observational studies - The Cinderella of the Italian research system11
Cardiovascular toxicity associated with the multitargeted tyrosine kinase inhibitor anlotinib10
Transient asymptomatic pulmonary opacities and interstitial lung disease in EGFR-mutated non-small cell lung cancer treated with osimertinib10
Exploratory analysis of the professional quality of life in an Italian radiotherapy department: The role of empathy and alexithymia10
Clinical difference between solitary and multiple pulmonary adenocarcinoma nodules10
Fertility and abortion: A population-based comparison between women with cancer and those in childbearing age10
The molecular tumor board: a tool for the governance of precision oncology in the real world8
Vaginal cancer treated with curative radiotherapy with or without concomitant chemotherapy: oncologic outcomes and prognostic factors8
KRAS inhibitors in drug resistance and potential for combination therapy8
Risk factors for primary site necrosis after definitive concurrent chemoradiotherapy in head and neck cancer8
Corrigendum to: AIRO Breast Cancer Group Best Clinical Practice 2022 Update8
Stereotactic body radiotherapy in oligoprogressive metastatic castration-resistant prostate cancer during abiraterone or enzalutamide8
Clinical predictors for biochemical failure in patients with positive surgical margin after robotic-assisted radical prostatectomy7
Study of Gene Expression of Programmed Cell Death Ligand 1 (PD-L1) in Breast Cancer Patients7
Role of radium-223 discontinuation due to adverse events in castration-resistant prostate cancer patients. A retrospective monocentric analysis7
Effect of body mass index on immune checkpoint inhibitor efficacy in patients with advanced cancer7
A new era for bladder cancer: Enfortumab vedotin and pembrolizumab milestone approval7
Secular trends in incidence and mortality of non-Hodgkin’s lymphoma in China, 1990–2019, and predictions to 2030: Outlook for the future burden of disease7
Electronic cigarette, or vaping, product use-associated lung injury (EVALI) in a patient with testicular cancer: A case report7
PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors7
Combined CAR-T/HSCT approach in a patient with refractory acute lymphoblastic leukemia and cystic fibrosis6
Treating rare tumors with the assistance of the expert virtual consultation system: two cases of juvenile granulosa cell tumors6
Fat necrosis after accelerated partial breast irradiation or hypofractionated whole breast irradiation: A case-control study6
Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund6
Clinical heterogeneity and reduced penetrance in DICER1 syndrome: a report of three families6
Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial6
Fears, beliefs, and quality of life of patients with cancer vs the general population during the coronavirus disease 2019 (COVID-19) pandemic in Lombardy6
The efficacy and safety of anlotinib for subsequent line treatment of small cell lung cancer: a systematic review and meta-analysis6
Two different patterns of lung adenocarcinoma with concomitant EGFR mutation and ALK rearrangement5
15th BGICC Abstract Book 20235
Hippocampal Dosimetric Evaluation in Locally Advanced Nasopharyngeal Carcinoma Patients Treated with Intensity Modulated Radiotherapy5
Novel insights into RB1 in prostate cancer lineage plasticity and drug resistance5
Small tongue squamous cell carcinoma with neck metastasis at diagnosis: operative insights and surgical technique5
Four pathogenic variants co-occurring in a MINAS early-onset breast cancer5
Out Come of Wide Local Excision with and without Corticosteroid Therapy in Management of Idiopathic Granulomatous Mastitis5
Radiotherapy in prostate cancer after kidney transplant in 6 cases5
Gastric cancer detection using the serum pepsinogen test method5
Chemoprevention strategies in hereditary breast and ovarian cancer syndromes5
Colorectal medullary carcinoma: heterogeneous presentations of a rare clinico-pathological entity. Report of two cases4
Is motherhood still possible after pelvic carbon ion radiotherapy? A promising combined fertility-preservation approach4
Chemo-surgical approach in vulvar leiomyosarcoma: A case report4
Impact of the STK11/KRAS co-mutation on the response to immunotherapy in a real-world pan-cancer cohort4
Implications and mechanisms of O-GlcNAcylation in cancer therapy resistance4
Efficacy of 3 Monthly versus Monthly Zoledronic Acid on Bone Metastasis4
Efficacy and Safety of Lapatinib in Elderly Egyptian Patients with Her2 neu Positive Metastatic Breast Cancer4
Efficacy of lenvatinib plus pembrolizumab in hepatocellular carcinoma with metachronous lung metastasis: a report of two cases4
The effect of peripheral regional analgesia in thoracic surgery: a systematic review and a meta-analysis of randomized-controlled trials4
Hippocampal region avoidance in whole brain radiotherapy in brain metastases: For all or for some? A real-world feasibility report4
Melanoma and sex hormones: Pathogenesis, progressive disease and response to treatments4
PARK7/DJ-1 inhibition decreases invasion and proliferation of uveal melanoma cells4
A systematic review and meta-analysis for human epidermal growth factor receptor 2 on upper tract urothelial carcinoma patients4
Oral vinorelbine in young patients with desmoid-type fibromatosis4
Alk-rearranged lung adenocarcinoma: From molecular genetics to therapeutic targeting4
Hypoxia-induced RNASEH2A limits activation of cGAS-STING signaling in HCC and predicts poor prognosis4
Impact of inter-observer variability on first axillary level dosimetry in breast cancer radiotherapy: An AIRO multi-institutional study4
A shared vaccination ambulatory for patients with cancer in Udine, Italy3
Neoadjuvant or adjuvant immunotherapy in bladder cancer: biological opportunity or clinical utility?3
The last journey, coming home before dying for migrant cancer patients: A case series3
Italian oncologists and vaccinations against infectious diseases: Results of a survey of the Italian Association of Medical Oncology3
Universal testing for COVID-19 in patients undergoing cancer treatment during the second outbreak in Brescia3
Comparative analysis of the quantitative parameter method and elasticity color mode method for real-time shear wave elastography in the diagnosis of benign and malignant solid breast lesions3
Response to Deantoni et al.3
Establishment of 6 pediatric rhabdomyosarcoma patient’s derived xenograft models closely recapitulating patients’ tumor characteristics3
Treating secondary malignant neoplasms: A burden of childhood cancer survivors3
Italian pediatric and adult oncology communities join forces for a national project dedicated to adolescents and young adults with cancer3
Lung metastasectomy for osteosarcoma in children, adolescents, and young adults: proof of permanent cure3
Blooming in the rain3
Expanding role of radiotherapy in adenoid cystic carcinoma of the tracheobronchial tree: a new horizon3
Cytokine release syndrome after CAR infusion in pediatric patients with refractory/relapsed B-ALL: is there a role for diclofenac?3
Adjuvant chemotherapy in elderly patients with HER2-negative early breast cancer: A systematic review and meta-analysis3
Current practices of follow-up programs for childhood cancer survivors in Italy3
Immunogenicity of radiotherapy on bone metastases from prostate adenocarcinoma: What is the future for the combination with radiotherapy/immunotherapy?3
Impact of low skeletal muscle mass in oropharyngeal cancer patients treated with radical chemo-radiotherapy: A mono-institutional experience3
Efficacy and safety of induction chemotherapy in oral cavity cancer: An eight-year experience at a Portuguese reference center3
First-line treatment of metastatic castration-resistant prostate cancer: the real-world Italian cohort of the Prostate Cancer Registry3
Acute myeloid leukemia: Incidence, transplantation and survival through Italian administrative healthcare data3
Delta-volume radiomics of induction chemotherapy to predict outcome of subsequent chemoradiotherapy for locally advanced hypopharyngeal cancer3
Prolonged COVID-19 infection in a child with lymphoblastic non-Hodgkin lymphoma: which is the best management?3
MLH1 promoter hypermethylation and Lynch Syndrome: When to test for constitutional epimutations of MLH1 gene?3
Monitoring patients with head and neck cancer for flu-like symptoms during the COVID-19 pandemic3
Correlation of Primary Tumor Metabolic Parameters with Clinical, Histopathological and Molecular Characteristics in Breast Cancer Patients at Preoperative Staging FDG-PET/CT Study3
0.11024808883667